Article Information
History
- December 25, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Tomohisa Tanaka1,
- Akatsuki Saito2,3,
- Tatsuya Suzuki4,
- Yoichi Miyamoto5,
- Kazuo Takayama6,
- Toru Okamoto4 and
- Kohji Moriishi1,7,*
- 1Department of Microbiology, Faculty of Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, Yamanashi 409-3898, Japan
- 2Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki, Miyazaki 889-2192, Japan
- 3Center for Animal Disease Control, University of Miyazaki, Miyazaki 889-2192, Japan
- 4Institute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
- 5Laboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka 567-0085, Japan
- 6Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan
- 7Center for Life Science Research, University of Yamanashi, Yamanashi 409-3898, Japan
- ↵*Corresponding author:
Kohji Moriishi, D.V.M., Ph.D., Department of Microbiology, Faculty of Medicine, Graduate Faculty of Interdisciplinary Research, University of Yamanashi, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan, Tel.: +81-55-273-1111, Fax: +81-55-273-6728, E-mail: kmoriishi{at}yamanashi.ac.jp
Posted December 25, 2021.
Establishment of a stable SARS-CoV-2 replicon system for application in high-throughput screening
